Form 4: Equillium Inc. Executive Acquires 175,000 Stock Options

Stephen Connelly, Chief Scientific Officer of Equillium, Inc., acquired 175,000 employee stock options on January 2, 2025.

Summary

• Stephen Connelly, the Chief Scientific Officer of Equillium, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on January 2, 2025, where Connelly acquired 175,000 employee stock options.
• The exercise price of these options is $0.77.
• The options vest over a period of four years, with 25% vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.
• The options expire on January 1, 2035.
• Following the reported transaction, Connelly directly owns 175,000 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting the grant of stock options, which is a neutral event.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.

Stakeholder Impact

• The granting of stock options can incentivize management to improve company performance, potentially benefiting shareholders.
• Employees may be motivated by the prospect of receiving stock options in the future.

Key Dates